Disease Info Card

Cystic Kidney Diseases

Information about Cystic Kidney Diseases: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Cystic Kidney Diseases

Most recent studies have shown that Cystic Kidney Diseases shares some biological mechanisms with adenocarcinoma, carcinoma, cystic-disease--retired-, hemorrhage, hydronephrosis, hypertensive-disease, infection-of-kidney, kidney-diseases, kidney-failure, kidney-failure-chronic, kidney-neoplasm, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, nephroblastoma, pain, polycystic-kidney-autosomal-dominant, polycystic-kidney-diseases, renal-cell-carcinoma, simple-renal-cyst.

Among the many pathways, these few ones have gauged particular interests from scientists studying Cystic Kidney Diseases, and have been seen in publications frequently: Cell Adhesion, Cell Cycle, Cell Death, Cell Division, Cell Growth, Cell Proliferation, Coagulation, Enucleation, Epithelial Cell Proliferation, Excretion, Fluid Transport, Glomerular Filtration, Intraflagellar Transport, Ion Transport, Kidney Development, Localization, Pathogenesis, Regeneration, Secretion, Transport

Quite a number of genes have been found to play important roles in Cystic Kidney Diseases, such as EGF, EGFR, EPO, HNF1B, INVS, MTOR, NPHP1, NPHP4, PCNA, PIK3C2A, PKD1, PKD2, PKHD1, PRKD1, PRKD2, REN, UMOD, VHL. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.